Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides

Endocrinology

Volumn 154, Issue 6, 2013, Pages 2234-2243

  Inaba, Hidefumi ^a,d   Moise, Leonard ^a,b   Martin, William ^b   De Groot, Anne S ^b   Desrosiers, Joe ^a   Tassone, Ryan ^b   Buchman, George ^c   Akamizu, Takashi ^d   De Groot, Leslie J ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b EpiVax Inc   (United States)

^c Chesapeake Protein Expression and Recovery Labs   (United States)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA DR3 ANTIGEN; PEPTIDE; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; THYROTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOTHERAPY; MALE; MOUSE; MUTANT; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; SPLEEN CELL; THYROID DISEASE; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GRAVES DISEASE; HLA-DR3 ANTIGEN; HUMANS; IMMUNE SERA; IMMUNIZATION; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; SPLEEN;

EID: 84878466493     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1033     Document Type: Article

References (27)

1. DeGroot LJ, Quintans J. The causes of autoimmune thyroid disease. Endocr Rev. 1989;10:537-562. (Pubitemid 20001023)
2. Couet J, Sar S, Jolivet A, Vu Hai MT, Miligrom E, Misrahi M. Shedding of human thyrotropin receptor ectodomain. J Biol Chem. 1996;271:4545-4552.
3. Soliman M, Kaplan E, Yanagawa T, Hidaka Y, Fisfalen ME, DeGroot LJ. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. J Clin Endocrinol Metab. 1995;80:905-914.
4. Inaba H, Martin W, De Groot AS, Qin S, De Groot LJ. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J Clin Endocrinol Metab. 2006;91:2286-2294. (Pubitemid 43855019)
5. Inaba H, Pan D, Shin YH, Martin W, Buchman G, De Groot LJ. Immune response of mice transgenic for human histocompatibility leukocyte Antigen-DR to human thyrotropin receptor-extracellular domain. Thyroid. 2009;19:1271-1280.
6. Inaba H, Martin W, Ardito M, De Groot AS, De Groot LJ. The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease. J Clin Endocrinol Metab. 2010;95:2909-2916.
7. Eschler DC, Hasham A, Tomer Y. Cutting edge: the etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol. 2011;41:190-197.
8. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80:41-45.
9. Hiratani H, Bowden DW, Ikegami S, et al. Multiple major alleles of SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab. 2005;90:2898-2903. (Pubitemid 40686341)
10. Wellcome Trust Case Control Consortium. Association scan of 14 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007 39:1329-1337.
11. Serrano NC, Millan P, Páez MC. Non-HLA associations with autoimmune diseases. Autoimmun Rev. 2006;5:209-214. (Pubitemid 43234186)
12. Moise L, Song C, Martin WD, Tassone R, De Groot AS, Scott DW. Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo. Clin Immunol. 2012;142:320-331.
13. Katsara M, Yuriev E, Ramsland PA, et al. A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-γ responses. J Neuroimmunol. 2008;200:77-89.
14. Flynn JC, Rao PV, Gora M, et al. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol. 2004;135:35-40. (Pubitemid 38067925)
15. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology. 2006;147:4036-4043. (Pubitemid 44268357)
16. Endo T, Ohmori M, Ikeda M, Onaya T. Thyroid stimulating activity of rabbit antibodies toward the human thyrotropin receptor peptide. Biochem Biophys Res Commun. 1991;31;177:145-150.
17. Kosugi S, Ban T, Akamizu T, Kohn LD. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimula-ting blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol. 1992;6:168-180.
18. Schwarz-Lauer L, Pichurin PN, Chen CR, et al. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003;144:1718-1725. (Pubitemid 36543308)
19. Hidaka Y, Guimaraes V, Soliman M, et al. Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. Endocrinology. 1995;136:1642-1647.
20. Chazenbalk GD, Pichurin P, Chen CR, et al. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest. 2002;110:209-217. (Pubitemid 34787358)
21. McLachlan SM, Nagayama Y, Rapoport B. Insight into Graves' hyperthyroidism from animal models. Endocr Rev. 2005;26:800-832. (Pubitemid 41428539)
22. Morris JC, Bergert ER, McCormick DJ. TSH binding structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem. 1993;268:10900-10905. (Pubitemid 23162271)
23. Oda Y, Sanders J, Evans M, et al. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid. 2000;10:1051-1059. (Pubitemid 32095073)
24. Johnstone AP, Cridland JC, Da Costa CR, Nussey SS, Shepherd PS. A functional site on the human TSH receptor: a potential therapeutic target in Graves' disease. Clin Endocrinol (Oxf). 2003;59:437-441. (Pubitemid 37188173)
25. Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism. Thyroid. 2006;16:1221-1227. (Pubitemid 46080166)
26. Michalek K, Morshed SA, Latif R, Davies TF. TSH receptor autoantibodies. Autoimmun Rev. 2009;9:113-116.
27. Kappler JW, Roehm N, Marrack P. T-cell tolerance by clonal elimination in the thymus. Cell. 1987;49:273-280.